|
| |||||||||||||||||||||||||||||||||||||
Over the past 20 years, we analyzed stones obtained from 74 patients with a diagnosis of primary hyperoxaluria type 1 established on the basis of complete urinary biochemical tests and evidence of an enzyme defect. In addition to findings on infrared spectroscopy, we examined the morphologic characteristics of the surface and sections of calculi by means of a stereomicroscope.5 All primary hyperoxaluria type 1 calculi were composed of pure or virtually pure (>95%) calcium oxalate monohydrate, or whewellite. As compared with idiopathic calcium stones with a similarly high whewellite content, all primary hyperoxaluria type 1 calculi showed very peculiar morphologic characteristics, including a whitish or pale-yellow surface and a loose, unorganized section, quite different from the dark-brown surface and well-organized, radiating inner structure of common whewellite stones (Figure 1). In addition, scanning electron microscopy confirmed a crystalline structure in the primary hyperoxaluria type 1 stone that was distinct from that of the common type of whewellite stone. This unique morphologic characteristic and the ultrastructure of primary hyperoxaluria type 1 stones suggest a fundamental difference in the mechanism of stone formation, reflecting the very rapid and permanent crystal formation induced by genetic hyperoxaluria. The peculiar morphologic characteristics of stones consistently observed in patients with primary hyperoxaluria type 1 (and in the two patients with primary hyperoxaluria type 2 whose stones were analyzed at our laboratory) appeared to be pathognomonic for this cause, since it was never observed in patients with other hyperoxaluric states (including 45 patients with enteric hyperoxaluria) or in any patient in whom a calcium stone formed without hyperoxaluria. Therefore, such appearance of stones might be a valuable indicator of primary hyperoxaluria type 1, prompting early comprehensive laboratory evaluation, including measurements of urinary oxalate, glycolate, and glycerate in order to achieve a definitive diagnosis.
|
Michel Daudon, Ph.D.
Paul Jungers, M.D.
Necker Hospital
75015 Paris, France
michel.daudon{at}nck.aphp.fr
Dominique Bazin, Ph.D.
Paris-Sud University
91405 Orsay, France
Supported by the Centre National de la Recherche Scientifique and Paris-Sud University.
| |||||||||||||||||||||||||||||||||||||
Related Letters:
Stones in Primary Hyperoxaluria A Clarification
Daudon M., Jungers P., Bazin D.
Extract |
Full Text |
PDF
N Engl J Med 2009;
360:1680, Apr 16, 2009.
Correspondence
This article has been cited by other articles:
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |